Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Assembly Biosciences patents new compounds for HBV

Nov. 17, 2021

Soluble ACE2 decoy peptide ameliorates SARS-CoV-2 lung vascular injury

Nov. 16, 2021

Systems biology approaches unveil in vivo commensal control of Clostridioides difficile virulence

Nov. 15, 2021

PA-001 for COVID-19 completes preclinical testing

Nov. 15, 2021

Assembly Biosciences synthesizes new HBV antivirals

Nov. 15, 2021

Fitness cost of antibiotic-resistant mutants can be used to identify new combination therapies

Nov. 12, 2021

COVA1-18 demonstrates strong antiviral activity against SARS-CoV-2 in vivo

Nov. 12, 2021

New compounds inhibiting respiratory syncytial virus identified at Janssen

Nov. 12, 2021

Zika-specific therapy found to protect fetal mouse brains

Nov. 11, 2021

Gritstone's self-amplifying mRNA vaccination protected against SARS-CoV-2 challenge in NHPs

Nov. 10, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...